甘肅電投(000791.SZ):炳靈公司擬增加註冊資本金約1.39億元
格隆匯3月27日丨甘肅電投(000791.SZ)公佈,、公司控股子公司甘肅電投炳靈水電開發有限責任公司(“炳靈公司”)擬增加註冊資本金13888.89萬元,公司持有炳靈公司90%的股權,此次擬增資1.25億元,中國電建集團西北勘測設計研究院有限公司(“西北院”)持有炳靈公司10%的股權,此次等比例增資1388.89萬元,此次增資完成後,炳靈公司股權比例不變。
此次對炳靈公司增資是為了降低資金使用成本,改善子公司財務結構,此次對炳靈公司增資不會產生新的風險。此次增資前後炳靈公司均為公司控股子公司,公司持有炳靈公司的股權比例不變,不會影響公司的合併財務報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.